AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mycodapt S 360mg Tablet DR

Prescription Icon
Prescription Required

Marketer

Vyapitus Specialities Pvt Ltd

Salt Composition

Mycophenolate sodium (360mg)

Overview Mycodapt S 360mg Tablet DR

Immunosuppressant Mycodapt S 360mg Tablet DR is administered post-transplant to prevent organ rejection (kidney, heart, liver, etc.). Its mechanism involves immune system suppression, hindering the body's attack on the transplanted organ. Dosage is transplant-specific; adhere strictly to your physician's prescription. Consumption with or without food is acceptable; swallow whole – do not crush, chew, or break the tablet. Continuous use is crucial for optimal efficacy and rejection prevention; discontinuation raises rejection risk. Treatment duration is determined by individual needs. Common side effects include gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), headache, hypertension, and altered white blood cell counts. Immunosuppression increases infection susceptibility and cancer risk. A comprehensive list of potential side effects exists; discuss these with your doctor, noting that some warrant immediate medical attention. Mycodapt S 360mg Tablet DR is contraindicated during pregnancy, breastfeeding, or pregnancy planning due to teratogenic and abortifacient potential. Prior to commencing treatment, disclose any infections, unusual bleeding/bruising, or prior digestive issues. Report any unexplained bruising or bleeding, sore throat, mouth sores, or fever. Complete disclosure of all other medications is essential due to potential drug interactions. Regular blood tests will monitor blood cell counts.

Primary Ingredients of Mycodapt S 360mg Tablet DR

The provided text is "undefined," which has no meaning to rephrase. A rephrased version cannot be provided.

Uses of Mycodapt S 360mg Tablet DR

Preventing transplant organ rejection

Major Benefits of Mycodapt S 360mg Tablet DR:

Consume Mycodapt S 360mg Tablet DR precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.

Common Side effects of Mycodapt S 360mg Tablet DR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Mycodapt S 360mg Tablet DR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mycodapt S 360mg Delayed-Release Tablets may be consumed with or without food, although consistent timing is recommended.

How Mycodapt S 360mg Tablet DR works:

Mycodapt S 360mg Delayed-Release Tablets function as an immunosuppressant medication, suppressing the body's natural immune response to prevent organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from combining Mycodapt S 360mg Tablet DR with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Mycodapt S 360mg Delayed-Release Tablets during pregnancy poses a confirmed risk to the fetus. While a physician might exceptionally prescribe it in life-threatening emergencies where benefits outweigh the risks, it's not advised. Always seek medical counsel.

Breast feedingBreast feedingUNSAFE

Using Mycodapt S 360mg Tablet DR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the drug poses a risk to nursing infants.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mycodapt S 360mg Delayed-Release Tablets.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using Mycodapt S 360mg sustained-release tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Mycodapt S 360mg Tablet DR in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary, however, physician consultation is recommended.

What if you forget to take Mycodapt S 360mg Tablet DR :

For Mycodapt S 360mg Delayed-Release Tablets, take a missed dose promptly if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mycodapt S 360mg Tablet DR

LabelValue
Chemical Type Phthalide-based compound
Developing Habits No.
Treatment Category Cancer Therapeutics
Actions Purine analog immunosuppressants

FAQs on Mycodapt S 360mg Tablet DR

Mycodapt S 360mg Tablet DR is an immunosuppressant prescribed to help your body accept your transplanted kidney. It achieves this by suppressing your immune system's rejection of the donor organ.
Mycodapt S 360mg Tablet DR may raise your risk of skin cancer and lymphoma. Minimize sun exposure by wearing protective clothing and sunscreen when outdoors. Consult your doctor immediately if you develop any new skin lesions, changes in existing moles, unusual sores, persistent skin changes, non-healing sores, unexplained fever, fatigue, weight loss, or swollen lymph nodes (neck, groin, or armpits).
Mycodapt S 360mg Tablet DR, a non-steroid, non-chemotherapy immunosuppressant, works by weakening the immune system to prevent organ rejection. Hair loss is a frequent side effect.
To monitor your blood count, kidneys, and liver while taking Mycodapt S 360mg Tablet DR, your doctor will order blood tests before and regularly throughout your treatment. These tests track your response to the medication and help detect any potential side effects.
Mycodapt S 360mg Tablet DR weakens your immune system. Because your immunity is already compromised, contact with chickenpox or shingles could lead to infection. Your doctor's caution is therefore crucial. Contact them immediately if you develop either illness, as specialized treatment may be necessary.
Avoid Mycodapt S 360mg Tablet DR if pregnant or planning pregnancy. First-trimester use carries a high risk of miscarriage and birth defects. Therefore, use two reliable forms of contraception concurrently for four weeks before, throughout treatment, and for six weeks after stopping Mycodapt S 360mg Tablet DR. Your doctor will recommend suitable methods. Note that Mycodapt S 360mg Tablet DR can reduce the efficacy of birth control pills, necessitating a second form of contraception.
Reliable contraception should be used by either the man or his partner throughout treatment and for 90 days afterward. Men must refrain from donating semen during and for 90 days after Mycodapt S 360mg Tablet DR treatment.
Mycodapt S 360mg Tablet D...
788